Search Results

Keywords: "Controlled Substances Act"

Racketeering lawsuits remain a liability for marijuana businesses, but companies can head off risks

February 1, 2021 · Updated September 15, 2021

Federal racketeering lawsuits against state-legal marijuana businesses might be in something of a lull right now, but they remain a risk to be factored in with other business costs, experts agree. “We still see it as a significant risk for marijuana growers—although maybe one that is slowing a bit,” said Gerald Arth, a partner in […]

Read More

A marijuana pioneer changes course: Q&A with Harborside co-founder Steve DeAngelo

January 15, 2021 · Updated October 8, 2021

Steve DeAngelo is one of the marijuana industry’s most high-profile pioneers. But earlier this month, DeAngelo and the Oakland, California-based company he co-founded in 2006, Harborside, formally parted ways. Moreover, the role of chair emeritus, which DeAngelo held starting in 2018, was eliminated. “I wish Harborside the very best as it continues to promote wellness […]

Read More

Major federal marijuana reform could hinge on outcome of two Georgia Senate races

January 5, 2021 · Updated January 15, 2021

All eyes are on Georgia and two runoff races Tuesday that will determine whether the U.S. Senate flips to Democrats, an outcome that could make the upper chamber more amenable to federal marijuana reform – perhaps even legalization. Potentially billions of dollars of business opportunities are at stake, depending on the scope and shape of […]

Read More

US House passes bill to expedite, expand medical cannabis research

December 9, 2020

The U.S. House of Representatives on Wednesday passed a groundbreaking bill to reduce barriers and expand scientific research into medical cannabis, a move that could be critical to convincing Republican lawmakers to support broader marijuana reform. One aspect of the measure would enable researchers to study medical marijuana products sold in state-legal markets to better […]

Read More

Full US House expected to take up medical cannabis research bill

December 8, 2020

The U.S. House of Representatives is poised to vote on a bill this week to accelerate medical cannabis research, a move that could strengthen support for broader reform. The vote, expected as soon as Wednesday, comes on the heels of the House passing a historic measure last week to remove marijuana from the federal Controlled […]

Read More

DEA asks court to toss marijuana rescheduling appeal

December 3, 2020 · Updated September 2, 2021

The U.S. Drug Enforcement Administration reiterated that a lawsuit challenging marijuana’s classification as a Schedule 1 drug under the federal Controlled Substances Act should be dismissed because of lack of jurisdiction and merit. The DEA’s assertion came in a 77-page response to a case in the 9th Circuit Court of Appeals in San Francisco. In […]

Read More